Zhengye Biotechnology Holding Limited (ZYBT)

Market Cap	76.30M -83.5%
Revenue (ttm)	16.64M -37.6%
Net Income	-9.98M
EPS	-0.21
Shares Out	47.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,108
Open	1.660
Previous Close	1.630
Day's Range	1.600 - 1.710
52-Week Range	0.616 - 11.452
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 28, 2026

About ZYBT

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 7, 2025
• Employees: 269
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYBT
• Website: https://www.jlzybio.com

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 5, 2026

Data Sources Report a data error